首页> 外文期刊>Advanced Functional Materials >Non-Fenton-Type Hydroxyl Radical Generation and Photothermal Effect by Mitochondria-Targeted WSSe/MnO_2 Nanocomposite Loaded with Isoniazid for Synergistic Anticancer Treatment
【24h】

Non-Fenton-Type Hydroxyl Radical Generation and Photothermal Effect by Mitochondria-Targeted WSSe/MnO_2 Nanocomposite Loaded with Isoniazid for Synergistic Anticancer Treatment

机译:异烟肼负载线粒体靶向的WSSe / MnO_2纳米复合材料的非Fenton型羟基自由基产生和光热效应,用于协同抗癌治疗。

获取原文
获取原文并翻译 | 示例

摘要

Here, in terms of the highly reactive oxidative hydroxyl radical (center dot OH) generation ability of isoniazid (INH) catalyzed by Mn2+ ion and the photothermal effect of WSSe nanoflakes, a WSSe/MnO2-INH nanocomposite for synergistic anticancer treatment is developed. Advanced INH-induced center dot OH formation ability is systemically demonstrated in the presence of manganese and relevant non-Fenton-type mechanism, and good photothermal conversion efficiency of the WSSe/MnO2 nanocomposite. After modifying with mitochondria-targeted triphenylphosphonium bromide (TPP) moieties and camouflaging with cancer cells membrane (WSSe/MnO2-INH-TPP@CM), it confers a sequential cell-to-mitochondria targeting ability. In vivo X-ray computed tomography and magnetic resonance tumor imaging capability of the nanocomposite are also revealed. The mitochondria-targeted oxidative damage and photothermal therapy by WSSe/MnO2-INH-TPP@CM results in excellent anticancer treatment efficacy both in vitro and in vivo. This is the first exploration of the possibility of non-Fenton-type center dot OH formation for anticancer treatment, which opens new opportunities for ROS-based and combined cancer treatment strategies.
机译:在此,根据Mn2 +离子催化的异烟肼(INH)的高反应性氧化羟基自由基(中心点OH)生成能力和WSSe纳米薄片的光热效应,开发了用于协同抗癌治疗的WSSe / MnO2-INH纳米复合材料。在锰和相关的非芬顿型机理的存在下,系统地证明了先进的INH诱导的中心点OH形成能力,并且WSSe / MnO2纳米复合材料具有良好的光热转化效率。用线粒体靶向的三苯基溴化bro(TPP)部分修饰并用癌细胞膜(WSSe / MnO2-INH-TPP @ CM)伪装后,它赋予了连续的细胞对线粒体靶向能力。还揭示了纳米复合材料的体内X射线计算机断层扫描和磁共振肿瘤成像能力。 WSSe / MnO2-INH-TPP @ CM的线粒体靶向氧化损伤和光热疗法在体内和体外均具有出色的抗癌治疗效果。这是首次探索形成非Fenton型中心点OH进行抗癌治疗的可能性,这为基于ROS的和联合的癌症治疗策略提供了新的机遇。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号